Menu Close

Articles on Clinical research

Displaying all articles

Do the benefits of approving a drug before confirming it works outweigh the potential costs? monkeybusinessimages/iStock via Getty Images Plus

The FDA’s big gamble on the new Alzheimer’s drug

The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
Experts have called for a moratorium on clinical research with CRISPR/Cas9 gene editing. of the germline — that is changing heritable DNA in sperm, eggs or embryos to make genetically modified children. (Shutterstock)

CRISPR gene editing: Why we need Slow Science

CRISPR gene editing should learn from the Slow Food movement. Scientists must allow time for critical conversations and perfecting of techniques before rewriting the source code of humanity.

Top contributors

More